Columbia's team of surgical innovators are developing and refining mini-invasive procedures, hybrid approaches, and novel ways to repair or reconstruct heart valves in children.
Christopher J. Petit, MD, internationally recognized for clinical innovation and excellence in interventional cardiology, has been appointed Director of Pediatric Cardiology.
During CPET Columbia cardio-physiologists put the pulmonary, cardiovascular, and skeletal muscle systems to work together to assess a child’s overall aerobic fitness.
Dr. Josh Milner studies rare causes of common diseases such as atopic dermatitis. He uses a step by step diagnostic approach to determine if there is an underlying genetic cause.
Dr. Adolfo Ferrando and his lab members focus primarily on deciphering the mechanisms that lead to chemotherapy resistance and relapse in acute lymphoblastic leukemia.
When Dr. Wendy Chung identified the Olson children's rare disease, “It was like someone turned on the flashlight, and at least now we have a vision of how to move forward," says their mother Colleen.
Priyanka Ahimaz and other genetic counselors educate patients about genetic disorders and help them navigate the complexities of having a genetic diagnosis.
Monica Bhatia, MD, director of Columbia’s Pediatric Stem Cell Transplant Program, is participating in a trial evaluating gene editing as a curative treatment for patients with sickle cell disease.
Over the past two years, the Department of Pediatrics has engaged in efforts to coalesce clinical, research, community, and educational endeavors at Columbia focused on pediatric obesity.
